Pharmaust Limited Statistics
Want to see AU:NUZ full AI Analyst Report?
Pharmaust Limited (NUZ) Stock Statistics & Valuation Metrics
Total Valuation
Pharmaust Limited has a market cap or net worth of AUD 49.61M. The enterprise value is AUD 36.12M.
- Market Cap
- AUD 49.61M
- Enterprise Value
- AUD 36.12M
Share Statistics
Pharmaust Limited has 855,368,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 855,368,100
- Owned by Insiders
- 3.64%
- Owned by Institutions
- ―
Financial Efficiency
Pharmaust Limited’s return on equity (ROE) is -0.84 and return on invested capital (ROIC) is -68.44%.
- Return on Equity (ROE)
- -0.84
- Return on Assets (ROA)
- -0.45
- Return on Invested Capital (ROIC)
- -68.44%
- Return on Capital Employed (ROCE)
- -2.18
- Revenue Per Employee
- 488.49K
- Profits Per Employee
- -297.86K
- Employee Count
- 36
- Asset Turnover
- 0.74
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pharmaust Limited is -3.31. Pharmaust Limited’s PEG ratio is -0.06.
- PE Ratio
- -3.31
- PS Ratio
- 0.00
- PB Ratio
- 3.46
- Price to FCF
- -3.29
- Price to Operating Cash Flow
- -2.92
- PEG Ratio
- -0.06
Income Statement
In the last 12 months, Pharmaust Limited had revenue of 17.59M and earned -10.72M in profits. Earnings per share was -0.02.
- Revenue
- 17.59M
- Gross Profit
- 17.59M
- Operating Income
- -27.76M
- Pretax Income
- -27.08M
- Net Income
- -10.72M
- EBITDA
- -27.75M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -15.07M and capital expenditures -8,223, giving a free cash flow of -15.08M billion.
- Operating Cash Flow
- -15.07M
- Free Cash Flow
- -15.08M
- Free Cash Flow per Share
- -0.02
Dividends & Yields
Pharmaust Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -30.40%
- Earnings Yield
- -24.37%
Stock Price Statistics
- Beta
- 0.46
- 52-Week Price Change
- -43.69%
- 50-Day Moving Average
- 0.08
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- 31.65
- Average Volume (3m)
- 597.74K
Important Dates
Pharmaust Limited upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Pharmaust Limited as a current ratio of 2.16, with Debt / Equity ratio of 26.02%
- Current Ratio
- 2.16
- Quick Ratio
- 2.16
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 0.34
- Interest Coverage Ratio
- -37.65
Taxes
In the past 12 months, Pharmaust Limited has paid -16.36M in taxes.
- Income Tax
- -16.36M
- Effective Tax Rate
- 0.60
Enterprise Valuation
Pharmaust Limited EV to EBITDA ratio is -1.45, with an EV/FCF ratio of -2.67.
- EV to Sales
- 0.00
- EV to EBITDA
- -1.45
- EV to Free Cash Flow
- -2.67
- EV to Operating Cash Flow
- -2.67
Balance Sheet
Pharmaust Limited has AUD 12.71M in cash and marketable securities with AUD 3.31M in debt, giving a net cash position of AUD 9.40M billion.
- Cash & Marketable Securities
- AUD 12.71M
- Total Debt
- AUD 3.31M
- Net Cash
- AUD 9.40M
- Net Cash Per Share
- AUD 0.01
- Tangible Book Value Per Share
- AUD 0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Pharmaust Limited is AUD 0.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- AUD 0.20
- Price Target Upside
- 244.83% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 47.31%
Scores
- Smart Score
- 5
- AI Score
- 40
